A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN

Spinal Muscular Atrophy (SMA) is a neuromuscular disease caused by decreased levels of the survival of motoneuron (SMN) protein. Post-translational mechanisms for regulation of its stability are still elusive. Thus, we aimed to identify regulatory phosphorylation sites that modulate function and sta...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Rademacher, S, Detering, NT, Schüning, T, Lindner, R, Santonicola, P, Wefel, I-M, Dehus, J, Walter, LM, Brinkmann, H, Niewienda, A, Janek, K, Varela, MA, Bowerman, M, Di Schiavi, E, Claus, P
Format:	Journal article
Język:	English
Wydane:	MDPI 2020

Podobne zapisy

A Single Amino Acid Residue Regulates PTEN-Binding and Stability of the Spinal Muscular Atrophy Protein SMN
od: Sebastian Rademacher, i wsp.
Wydane: (2020-11-01)

What could be the function of the spinal muscular atrophy-causing protein SMN in macrophages?
od: Ines Tapken, i wsp.
Wydane: (2024-05-01)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
od: Bowerman, M, i wsp.
Wydane: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
od: Bowerman, M, i wsp.
Wydane: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
od: Melissa Bowerman, i wsp.
Wydane: (2017-08-01)

The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
od: Niko Hensel, i wsp.
Wydane: (2020-02-01)

Spinal muscular atrophy in Venezuela: quantitative analysis of SMN1 and SMN2 genes
od: Yuri Yépez, i wsp.
Wydane: (2020-06-01)

Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
od: Darija Šoltić, i wsp.
Wydane: (2020-03-01)

SMN post-translational modifications in spinal muscular atrophy
od: Giulietta M. Riboldi, i wsp.
Wydane: (2023-02-01)

CORRIGENDUM to Molecular Crosstalk Between Non-SMN-Related and SMN-Related Spinal Muscular Atrophy
Wydane: (2020-04-01)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
od: Winkelsas, AM, i wsp.
Wydane: (2021)

Therapy Development for Spinal Muscular Atrophy in SMN Independent Targets
od: Li-Kai Tsai
Wydane: (2012-01-01)

Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
od: Audrey M. Winkelsas, i wsp.
Wydane: (2021-03-01)

Quantitative and structural features of the SMN1 and SMN2 genes in patients with spinal muscular atrophy 5q
od: A. I. Vlasenko, i wsp.
Wydane: (2024-12-01)

SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy
od: Valeria Valsecchi, i wsp.
Wydane: (2023-11-01)

The spinal muscular atrophy disease protein SMN is linked to the Golgi network.
od: Chen-Hung Ting, i wsp.
Wydane: (2012-01-01)

Restoring SMN Expression: An Overview of the Therapeutic Developments for the Treatment of Spinal Muscular Atrophy
od: Tejal Aslesh, i wsp.
Wydane: (2022-01-01)

Molecular and Epidemiological Characterization of SMN Genes in Cuban Patients with Spinal Muscular Atrophy
od: Fabián Lombillo-Alfonso, i wsp.
Wydane: (2020-01-01)

Molecular And Epidemiological Characterization Of SMN Genes In Cuban Patients With Spinal Muscular Atrophy
od: Fabián Lombillo, i wsp.
Wydane: (2019-05-01)

Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
od: Claribel D Wee, i wsp.
Wydane: (2014-01-01)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
od: Niba, Emma Tabe Eko, i wsp.
Wydane: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
od: Niba, Emma Tabe Eko, i wsp.
Wydane: (2022)

P719: SMN1 deletion and silent carrier screening for spinal muscular atrophy
od: Poh San Lai, i wsp.
Wydane: (2024-01-01)

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy
od: Matthew E.R. Butchbach, i wsp.
Wydane: (2007-08-01)

The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy
od: W. Arnold, i wsp.
Wydane: (2016-03-01)

Investigation of a recombinant SMN protein delivery system to treat spinal muscular atrophy
od: Anderton Ryan, i wsp.
Wydane: (2014-03-01)

Targeting RNA structure in SMN2 reverses spinal muscular atrophy molecular phenotypes
od: Amparo Garcia-Lopez, i wsp.
Wydane: (2018-05-01)

P423: SMN1 SMN2 gene-specific sequencing enhances the clinical sensitivity of spinal muscular atrophy diagnostic testing
od: Matthew Avenarius, i wsp.
Wydane: (2023-01-01)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
od: Wishart, T, i wsp.
Wydane: (2010)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
od: Winkelsas, AM
Wydane: (2020)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
od: Leow, Damien Meng-Kiat, i wsp.
Wydane: (2024)

Patient-specific responses to SMN2 splice-modifying treatments in spinal muscular atrophy fibroblasts
od: Ilaria Signoria, i wsp.
Wydane: (2024-12-01)

Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls.
od: Christian Czech, i wsp.
Wydane: (2015-01-01)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
od: Owen, N, i wsp.
Wydane: (2002)

Characteristics of genetic changes in the <i>SMN1</i> gene in spinal muscular atrophy 5q
od: A. V. Dil, i wsp.
Wydane: (2022-09-01)

Recombinant SMN protein synergizes with spinal muscular atrophy therapy to counteract pathological motor neuron phenotypes
od: Liliana Brambilla, i wsp.
Wydane: (2024-12-01)

Depletion of SMN protein in mesenchymal progenitors impairs the development of bone and neuromuscular junction in spinal muscular atrophy
od: Sang-Hyeon Hann, i wsp.
Wydane: (2024-02-01)

Systems biology investigation of cAMP modulation to increase SMN levels for the treatment of spinal muscular atrophy.
od: Sean G Mack, i wsp.
Wydane: (2014-01-01)

In Vivo Translatome Profiling in Spinal Muscular Atrophy Reveals a Role for SMN Protein in Ribosome Biology
od: Paola Bernabò, i wsp.
Wydane: (2017-10-01)

SMN1 and NAIP Genes Deletions in Different Types of Spinal Muscular Atrophy in Khuzestan Province, Iran
od: Gholamreza Mohamadian, i wsp.
Wydane: (2011-12-01)